Overdose data to action (OD2A) in states - massachusetts - massachusetts (MA) will implement a comprehensive and cohesive program to track and prevent nonfatal and fatal overdoses while also…

Active Cooperative Agreement Awarded Last action

Award ID
NU17CE010190
Recipient
Awarding agency
Obligated
$34,046,543

Award facts

Completion date 63% complete
Funding agency
National Center for Injury Prevention and Control Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Description

Overdose data to action (OD2A) in states - massachusetts - massachusetts (MA) will implement a comprehensive and cohesive program to track and prevent nonfatal and fatal overdoses while also identifying emerging drug threats. Using data to inform prevention efforts, the MA department of public health (mdph) aims to reduce drug overdose mortality and morbidity in MA over the next five years by implementing all the surveillance and prevention strategies in the overdose data to action in states funding opportunity. While MA has made progress addressing the opioid epidemic, drug use and overdose remain very serious public health crises in the state. In 2020, MA had the fifth highest rate of opioid overdose-related death in the united states. While MA saw an encouraging decrease in opioid-related overdose deaths from 2016 to 2019, rates increased again each year of the covid-19 pandemic, including an increase of 11% from 2020 to 2021. People who were non-hispanic american indian and non-hispanic black experienced the largest percentage increase in opioid overdose death rates from 2018 to 2021, with rates increasing by 103% and 146% respectively. To address this need, MA will enhance the significant foundation developed with the previous MA overdose data to action (OD2A) cooperative agreement. Over the last several years, the state built strong systems to monitor trends rigorously and rapidly and to comprehensively respond to and prevent opioids, stimulants, and polysubstance misuse. Mdph's proposal reflects an interdisciplinary response that MA has crafted with significant internal and external partnerships reflecting its commitment to achieving health equity and reducing disparities in drug overdose. Mdph aims to reduce fatal and non-fatal drug overdoses, reduce disparities in drug overdoses, and increase health equity among those disproportionately affected by the overdose epidemic and those previously underserved by overdose prevention programs and the health care system. During the period of performance, mdph expects to achieve timely, detailed, comprehensive, and actionable surveillance data; increased data dissemination; increased data sharing and data availability; increased clinician awareness of evidence-based practices for pain management; increased clinician expertise and confidence to provide equitable opioid use disorder (OUD) and stimulant use disorder (stud) care; increased collaboration, coordination, and communication among partners; and increased use of navigators to link persons who use drugs (pwud) to care and services. Mdph will implement all required surveillance and prevention strategies. The surveillance OD2A-s funding will allow mdph to support the continued surveillance staffing and data infrastructure, to continue to collect and report syndromic surveillance data from 100% of MA hospital emergency departments, and to continue to collect and report all three required data sources on all unintentional and undetermined intent drug overdose deaths occurring in MA. To prevent drug overdoses, mdph will increase clinician expertise and confidence to provide evidence-based pain management, and equitable OUD and stud care; ensure access to out-of-state data for MA health care entities that have integrated their EHR into MA's prescription drug monitoring web portal; support a prescriber warmline to bridge prescription needs for patients experiencing a buprenorphine treatment disruption and work in partnership with public health, public safety, and clinical providers to prepare for future disruptions; expand and enhance overdose education and naloxone distribution services by using navigators to connect black and hispanic pwud to services and expand access to drug checking for pwud; and place recovery support navigators in hospitals and peer recovery support centers in areas of that state with high rates of disproportionately impacted populations.

Transactions

Action Obligated Date
Amendment CDC-RFA-CE-23-0002 overdose data to action (OD2A) in states - massachusetts - massachusetts (MA) will implement a comprehensive and cohesive program to track… $4,573,183
Amendment $0
Amendment CDC-RFA-CE-23-0002 overdose data to action (OD2A) in states - massachusetts - massachusetts (MA) will implement a comprehensive and cohesive program to track… $0
Amendment $4,210,480
Amendment $4,210,480
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $4,210,480
Amendment $4,210,480
Amendment $4,210,480
Amendment $4,210,480
Original award $4,210,480
Show all 16

Subawards

Subrecipient Amount Awarded
Gandara Mental Health Center Inc. Bsas substance use treatment $252,800
Gaamha Inc. $252,800
Trustees Of Boston University $35,738
Boston Medical Center Corporation $552,800
Brandeis University Bsas sustance use treatment $690,000
The Brien Center For Mental Health And Substance Abuse Services, Inc. Bsas substance use treatment $252,800
The Mercy Hospital, Inc. $152,800
Health Resources In Action, Inc. $1,137,096
Boston Medical Center Corporation Bsas substance use services $1,177,158
National Medical Services Inc. $102,606
Health Resources In Action, Inc. $250,000
Brandeis University BSAS Evaluation $690,000
The Brien Center For Mental Health And Substance Abuse Services, Inc. $252,800
Gaamha Inc. $252,800
Gandara Mental Health Center Inc. $252,800
Lawrence General Hospital Bsas evaluation $50,000
Trustees Of Boston University BSAS Evaluation $35,738
Boston Medical Center Corporation $1,610,718
The Mercy Hospital, Inc. Bsas evaluation $50,000
Trustees Of Boston University Substance Abuse Administrative Staff $150,000
Boston Medical Center Corporation Targeted Capacity Building for AOD $3,121,436
Brandeis University BSAS Evaluation $1,380,000
Brandeis University Substance Use Disorder Services $400,000
Justice Resource Institute, Inc. $30,173
Greater Lawrence Family Health Center, Inc. $75,000
Tapestry Health Systems, Inc. $50,000
Northeastern University $71,500
Brandeis University $400,000
Holyoke Health Center, Inc. $36,777
Fathers Uplift Inc. $75,000
Boston Medical Center Corporation $400,000
Argus Communications, Inc. $50,000
Show all 32

Quick answers

Who received award NU17CE010190?

NU17CE010190 was awarded to Massachusetts Department Of Public Health by Office of Financial Resources (Centers for Disease Control and Prevention) on September 1, 2023.

How much is award NU17CE010190 worth?

$34,046,543 has been obligated on NU17CE010190.

Which agency awarded NU17CE010190?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded NU17CE010190, with funding from National Center for Injury Prevention and Control (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award